Lonza unveils AI-powered route scouting service for small molecule development
This offering aims to streamline the identification of synthetic routes for novel active pharmaceutical ingredients (APIs) by using Lonza’s extensive chemical supply chain intelligence and in-house expertise, combined with AI technology from Elsevier (Reaxys). The development pipeline for small molecule APIs is becoming increasingly complex, driven by the intricate structures…